updated 9/17/2008 6:44:53 PM ET 2008-09-17T22:44:53

A government agency has dropped plans to test a controversial treatment for autism that critics had called an unethical experiment on children.

  1. Don't miss these Health stories
    1. Splash News
      More women opting for preventive mastectomy - but should they be?

      Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.

    2. Larry Page's damaged vocal cords: Treatment comes with trade-offs
    3. Report questioning salt guidelines riles heart experts
    4. CDC: 2012 was deadliest year for West Nile in US
    5. What stresses moms most? Themselves, survey says

The National Institute of Mental Health said in a statement Wednesday that the study of chelation (kee-LAY'-shun) has been discontinued. The statement says the agency decided the money would be better used testing other potential therapies for autism and related disorders.

The study had been on hold because of safety concerns. A study published last year linked a chemical used in the treatment to lasting brain problems in rats.

The treatment is based on the fringe theory that mercury in vaccines triggers autism — a theory never proved and rejected by mainstream science.

Chelation (kee-LAY’-shun) removes heavy metals from the body and is used to treat lead poisoning. Its use as an autism treatment is based on the fringe theory that mercury in vaccines triggers autism — a theory never proved and rejected by mainstream science. Mercury hasn’t been in childhood vaccines since 2001, except for certain flu shots.

But many parents of autistic children are believers in the treatment, and NIMH agreed to test it.

The researchers had proposed recruiting 120 autistic children ages 4 to 10 and giving half a chelation drug and the other half a dummy pill. The 12-week test would measure before-and-after blood mercury levels and autism symptoms.

The study outline said that failing to find a difference between the two groups would counteract “anecdotal reports and widespread belief” that chelation works.

Autism is a spectrum of disorders that hamper a person’s ability to communicate and interact with others. Most doctors believe there is no cure.

In canceling the study, the agency noted it would take another year to review the study and three years to do it. In the meantime, the agency said, it was likely that other research would “provide deeper understanding of the causes of autism and more refined avenues for developing treatments.”

Scientists applaud decision
Several scientists praised the decision, including the lead author of the rat study, which found lingering problems in animals that did not have elevated lead levels.

“I think they’re making the right decision not to go forward with the study,” said Barbara Strupp, a professor of psychology and nutritional sciences at Cornell University.

“Our data raise concerns about administering (the chelation compound) to children who do not have elevated levels of heavy metals,” Strupp said.

Dr. Paul Offit, chief of infectious diseases at the Children’s Hospital of Philadelphia, agreed with the decision to cancel.

“Suppose that a child suffers a severe side effect from chelation,” said Offit, author of “Autism’s False Prophets,” a new book on autism research. “Without any evidence it’s helpful, I think it’s unethical.”

The chelation drug proposed for the study, DMSA, can cause side effects including rashes and low white blood cell count.

“This was a wise and careful decision,” said Ellen Silbergeld of Johns Hopkins University’s Bloomberg School of Public Health, who had been invited to comment on the study during an earlier review, in an e-mail.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments